Abstract
Thymidine phosphorylase (EC 2.4.2.4) catalyses the reversible phosphorolysis of pyrimidine 2′-deoxynucleosides, forming 2-deoxyribose-1-phosphate and pyrimidine. 5-Chloro-6-(2-imino-pyrrolidin-1-yl)methyl-uracil hydrochloride (TPI, 1) and its 5-bromo analogue (2), 6-(2-amino-imidazol-1-yl) methyl-5-bromo-uracil (3) and its 5-chloro analogue (4) act as tight-binding stoichiometric inhibitors of recombinant E. coli thymidine phosphorylase, and thus can be used as the first active-site titrants for it using either thymidine or 5-nitro-2′-deoxyuridine as substrate. © 2006 Taylor & Francis.
| Original language | English |
|---|---|
| Pages (from-to) | 69-73 |
| Number of pages | 4 |
| Journal | Journal of Enzyme Inhibition and Medicinal Chemistry |
| Volume | 21 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - Feb 2006 |
Keywords
- Angiogenesis
- Anticancer drugs
- Inhibitors
- Stoichiometric inhibition
- Thymidine phosphorylase
- Transition state inhibitor